An Anti-CD28 Domain Antibody, Lulizumab, in Systemic Lupus Erythematosus: Results of a Phase II Study

被引：0
|
作者：
Merrill, Joan T. [1 ]
Shevell, Diane E. [2 ]
Duchesne, Dominique [2 ]
Nowak, Miroslawa [2 ]
Kundu, Sudeep [2 ]
Girgis, Ihab G. [2 ]
Hu, Yanhua Sarah [2 ]
Nadler, Steven G. [3 ]
Banerjee, Subhashis [2 ]
Throup, John [2 ]
机构：
[1] Oklahoma Med Res Fdn, Arthrit & Clin Immunol, 825 NE 13th St, Oklahoma City, OK 73104 USA
[2] Bristol Myers Squibb, Princeton, NJ USA
[3] Bristol Myers Squibb, Immunosci Translat Res, Princeton, NJ USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
REVISED CRITERIA; CLASSIFICATION;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
972
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The impact of glucocorticoids and anti-cd20 therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus
    Mendoza-Pinto, Claudia
    Garcia-Carrasco, Mario
    Vallejo-Ruiz, Veronica
    Taboada-Cole, Alejandro
    Munoz-Guarneros, Margarita
    Carlos Solis-Poblano, Juan
    Pezzat-Said, Elias
    Aguilar-Lemarroy, Adriana
    Felipe Jave-Suarez, Luis
    Vazquez de Lara, Luis
    Ramos-Alvarez, Gloria
    Reyes-Leyva, Julio
    Lopez-Colombo, Aurelio
    CLINICS, 2013, 68 (12) : 1475 - 1480
  • [42] Ant -Sm Antibody, Damage Index, and Corticosteroid Use Are Associated with Cardiac Involvement in Systemic Lupus Erythematosus: Data from a Prospective Registry Study
    Choe, Jung-Yoon
    Lee, Shin-Seok
    Kwak, Sang Gyu
    Kim, Seong-Kyu
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2020, 35 (21)
  • [43] CCR6+ Th cell distribution differentiates systemic lupus erythematosus patients based on anti-dsDNA antibody status
    Zhong, Wei
    Jiang, Zhenyu
    Wu, Jiang
    Jiang, Yanfang
    Zhao, Ling
    PEERJ, 2018, 6
  • [44] Comparisons of Anti-dsDNA Antibody Detection Methods by Chemiluminescent Immunoassay and Enzyme-Linked Immunosorbent Assay in Systemic Lupus Erythematosus
    Chang, Huang-Chen
    Wu, Yen-Ching
    Chen, Jun-Peng
    Wu, Yi-Da
    Huang, Wen-Nan
    Chen, Yi-Hsing
    Chen, Yi-Ming
    DIAGNOSTICS, 2021, 11 (11)
  • [45] Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial
    Wu, Di
    Li, Jing
    Xu, Dong
    Merrill, Joan T.
    van Vollenhoven, Ronald F.
    Liu, Yi
    Hu, Jiankang
    Li, Yang
    Li, Fen
    Huang, Chenghui
    Wang, Guochun
    Li, Xiaomei
    Zhao, Jianhong
    Zhao, Dongbao
    Huang, Cibo
    Liu, Huaxiang
    Wei, Wei
    Shi, Guixiu
    Lu, Fuai
    Zuo, Xiaoxia
    Bi, Liqi
    Li, Zhijun
    Wang, Xiaoxia
    Zhang, Miaojia
    Tie, Ning
    Li, Juan
    Mo, Hanyou
    Fang, Jianmin
    Bao, Chunde
    Zhang, Fengchun
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (04) : 475 - 487
  • [46] Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature
    Conti, Fabrizio
    Ceccarelli, Fulvia
    Perricone, Carlo
    Massaro, Laura
    Cipriano, Enrica
    Pacucci, Viviana Antonella
    Truglia, Simona
    Miranda, Francesca
    Morello, Francesca
    Alessandri, Cristiano
    Spinelli, Francesca Romana
    Valesini, Guido
    IMMUNOLOGIC RESEARCH, 2014, 60 (2-3) : 270 - 276
  • [47] Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjogren's Syndrome Post Hoc Analyses From the EMBODY Trials
    Gottenberg, Jacques-Eric
    Doerner, Thomas
    Bootsma, Hendrika
    Devauchelle-Pensec, Valerie
    Bowman, Simon J.
    Mariette, Xavier
    Bartz, Holger
    Oortgiesen, Marga
    Shock, Anthony
    Koetse, Willem
    Galateanu, Catrinel
    Bongardt, Sabine
    Wegener, William A.
    Goldenberg, David M.
    Meno-Tetang, Guy
    Kosutic, Gordana
    Gordon, Caroline
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (05) : 763 - 773
  • [48] Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus
    Merrill, Joan T.
    Furie, Richard
    Werth, Victoria P.
    Khamashta, Munther
    Drappa, Jorn
    Wang, Liangwei
    Illei, Gabor
    Tummala, Raj
    LUPUS SCIENCE & MEDICINE, 2018, 5 (01):
  • [49] Factors Associated with Survival and Discontinuation of Anti-Malarial Agents in Systemic Lupus Erythematosus: Results from a Tertiary Swedish Referral Centre
    Walhelm, Tomas
    Wirestam, Lina
    Enman, Yvonne
    Parodis, Ioannis
    Sjowall, Christopher
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [50] Anti-C1q Antibodies Are Associated With Systemic Lupus Erythematosus Global Activity but Not Specifically With Nephritis A Controlled Study of 126 Consecutive Patients
    Katsumata, Yasuhiro
    Miyake, Kohei
    Kawaguchi, Yasushi
    Okamoto, Yuko
    Kawamoto, Manabu
    Gono, Takahisa
    Baba, Sayumi
    Hara, Masako
    Yamanaka, Hisashi
    ARTHRITIS AND RHEUMATISM, 2011, 63 (08): : 2436 - 2444
12345